Comparison of efficacy and safety of empagliflozin vs linagliptin added to premixed insulin in patients with uncontrolled type 2 diabetes: A randomized, open-label study
| Autor: | Liu, S.-C., Lee, C.-C., Chuang, S.-M., Sun, F.-J., Zeng, Y.-H. |
|---|---|
| Zdroj: | In Diabetes & Metabolism May 2021 47(3) |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect